American Medical Association (AMA)

The American Medical Association (AMA) is the largest professional association and lobbying group of physicians and medical students. The AMA mission is to promote the art and science of medicine and the betterment of public health. The association represents physicians with a unified voice in courts and legislative bodies across the nation, removing obstacles that interfere with patient care, leading efforts to prevent chronic disease and confront public health crises, and driving the future of medicine to tackle the biggest challenges in healthcare.

Court dismisses nurse practitioners’ lawsuit challenging definition of ‘doctor’
The court's ruling is backed by the American Medical Association, which submitted an amicus brief arguing that "scope creep" threatens patient safety.
New-onset AFib is common after CABG—but typically not persistent or symptomatic
The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.
TAVR reinterventions: What new data tell us about redo, explant trends over time
TAVR reintervention rates remain low. However, they are slowly rising as the procedure is used more to treat patients with severe aortic stenosis. Researchers think this trend may continue going forward.
Real-world data link semaglutide, tirzepatide to improved heart failure outcomes
GLP-1 drugs have been taking the United States by storm in recent years. According to a new study of more than 90,000 patients, some of these medications can also make a big impact on reducing adverse heart failure outcomes.
MGMA warns of government overreach in the proposed 2026 Medicare Physician Fee Schedule
The Medical Group Management Association shares concerns about the draft fee schedule published in July. A major concern is the government possibly changing how RVUs are set, rather than allowing the medical specialty representatives to have a say.

ADHD medications and CVD: Lessons learned from a new meta-analysis of nearly 4 million patients

The new study, published in JAMA Network Open, should help ease any concerns patients may have about regularly taking ADHD medications.

OAC use among older AFib patients is on the rise

However, researchers noted, there is still considerable room for improvement.

AMA opposes criminalization of pregnancy loss

The American Medical Association (AMA) released a number of new policy adoptions, including several in reaction to the recently changed reproductive health laws in the United States.

Diabetes patients are experiencing fewer heart attacks and strokes as patient care continues to evolve

Patients with diabetes faced a much higher risk of a cardiovascular event in 1994 than they did in 2014, according to a new analysis published in JAMA.

Providers face ‘ominous reality’ of payment cuts as CMS finalizes 2023 Physician Fee Schedule

Physicians are now bracing for payment cuts after the Centers for Medicare and Medicaid Services (CMS) published its final rule for the 2023 Physician Fee Schedule.

AMA scrutinizes lack of competition, consumer harms in Medicare Advantage plans

Medicare Advantage plans face little in the way of competition, and Medicare consumers are worse off for it, according to a new study from the American Medical Association.

P2Y12 inhibitor monotherapy after PCI similar to prolonged DAPT, new 3-year analysis confirms

Researchers have shared an updated analysis of the SMART-CHOICE study, focusing on major adverse cardiac and cerebrovascular events—as well as bleeding events—among PCI patients after three years.

Healthcare groups ask DOJ for protection against violence over gender-affirming care

Three major healthcare groups are taking a stand against threats of violence over gender-affirming care by asking the Department of Justice to get involved.

American Medical Association (AMA)

Court dismisses nurse practitioners’ lawsuit challenging definition of ‘doctor’

New-onset AFib is common after CABG—but typically not persistent or symptomatic

TAVR reinterventions: What new data tell us about redo, explant trends over time

Real-world data link semaglutide, tirzepatide to improved heart failure outcomes

MGMA warns of government overreach in the proposed 2026 Medicare Physician Fee Schedule